Cargando…
The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough
The World Health Organization (WHO) assigns International Nonproprietary Names (INN) to pharmaceutical substances, including advanced therapy medicinal products, to ensure that each substance is globally recognized by a unique name. The majority of INN are published in the WHO Drug Information in ac...
Autores principales: | Loizides, Ursula, Dominici, Massimo, Manderson, Tony, Rizzi, Menico, Robertson, James S., de Sousa Guimarães Koch, Sofia, Timón, Marcos, Balocco, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111414/ https://www.ncbi.nlm.nih.gov/pubmed/33820700 http://dx.doi.org/10.1016/j.jcyt.2021.02.114 |
Ejemplares similares
-
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety
por: Robertson, James S., et al.
Publicado: (2022) -
International nonproprietary names for monoclonal antibodies: an evolving nomenclature system
por: Guimaraes Koch, Sofia S., et al.
Publicado: (2022) -
The INNs and outs of antibody nonproprietary names
por: Jones, Tim D., et al.
Publicado: (2015) -
WHO international non-proprietary names: the need to distinguish COVID-19 vaccines
por: Loizides, Ursula, et al.
Publicado: (2021) -
International nonproprietary names (INN) for pharmaceuticals substances : lists 1-73 of proposed INN and lists 1-35 of recomended INN cumulative list No. 9 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-73 de DCI proposées et listes 1-35 de DCI recommandées liste récapitulative No. 9
Publicado: (1996)